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Eukaryotic N-degron pathways are proteolytic systems whose uni-
fying feature is their ability to recognize proteins containing
N-terminal (Nt) degradation signals called N-degrons, and to target
these proteins for degradation by the 26S proteasome or auto-
phagy. GID4, a subunit of the GID ubiquitin ligase, is the main rec-
ognition component of the proline (Pro)/N-degron pathway. GID4
targets proteins through their Nt-Pro residue or a Pro at position 2,
in the presence of specific downstream sequence motifs. Here we
show that human GID4 can also recognize hydrophobic Nt-residues
other than Pro. One example is the sequence Nt-IGLW, bearing
Nt-Ile. Nt-IGLW binds to wild-type human GID4 with a Kd of 16 μM,
whereas the otherwise identical Nt-Pro–bearing sequence PGLW
binds to GID4 more tightly, with a Kd of 1.9 μM. Despite this differ-
ence in affinities of GID4 for Nt-IGLW vs. Nt-PGLW, we found that
the GID4-mediated Pro/N-degron pathway of the yeast Saccharo-
myces cerevisiae can target an Nt-IGLW–bearing protein for rapid
degradation. We solved crystal structures of human GID4 bound to
a peptide bearing Nt-Ile or Nt-Val. We also altered specific residues
of human GID4 and measured the affinities of resulting mutant
GID4s for Nt-IGLW and Nt-PGLW, thereby determining relative con-
tributions of specific GID4 residues to the GID4-mediated recogni-
tion of Nt-Pro vs. Nt-residues other than Pro. These and related
results advance the understanding of targeting by the Pro/N-degron
pathway and greatly expand the substrate recognition range of the
GID ubiquitin ligase in both human and yeast cells.
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Regulated protein degradation protects cells from misfolded,aggregated, and otherwise abnormal proteins, and also con-
trols the levels of proteins that evolved to be short-lived in vivo.
One function of protein degradation is the quality control of na-
scent and newly formed proteins. Selective proteolysis eliminates
proteins (including mutant ones) that fold too slowly, misfold, or
do not satisfy other requirements of quality control. The in-
tracellular protein degradation is mediated largely by the ubiquitin
(Ub)-proteasome system and autophagy-lysosome pathways, with
molecular chaperones being a part of both systems (1–18).
The ubiquitin (Ub)-proteasome system comprises pathways that
have in common at least two classes of enzymes, E3-E2 Ub ligases
and deubiquitylases (DUBs). A Ub ligase recognizes a substrate
protein through its degradation signal (degron) and conjugates
Ub, a 9-kDa protein (usually in the form of a poly-Ub chain), to an
amino acid residue (usually an internal lysine) of a targeted sub-
strate. The functions of DUBs include deubiquitylation of Ub-
conjugated proteins (2, 5, 10, 12, 19–24). The 26S proteasome, a
multisubunit ATP-dependent protease, binds to a ubiquitylated
protein substrate through a substrate-linked poly-Ub chain, un-
folds the protein using proteasomal ATPases (often with in-
volvement of the Cdc48/p97 unfoldase), and processively destroys
the protein to ∼10-residue peptides (25–32).
N-degron pathways (previously called “N-end rule pathways”)
are a set of proteolytic systems whose unifying feature is their
ability to recognize proteins containing N-terminal (Nt) degrada-
tion signals called N-degrons, thereby causing the degradation of
these proteins by the 26S proteasome or autophagy in eukaryotes,
and by the proteasome-like ClpAP protease in bacteria (2, 22,
33–74). N-degron pathways are Ub-dependent in eukaryotes but
not in bacteria. The main determinants of an N-degron include a
destabilizing Nt-residue of a protein substrate and an internal Lys
residue (or residues) that acts as the site of polyubiquitylation
(2, 34).
Initially, most N-degrons are pro–N-degrons. They are con-
verted to active N-degrons either constitutively (e.g., cotransla-
tionally) or conditionally, via regulated steps. Among the routes
to N-degrons are cleavages of proteins by proteases that include
Met-aminopeptidases (MetAPs), caspases, and calpains. These
and many other nonprocessive proteases function as initial tar-
geting components of N-degron pathways by cleaving a prosub-
strate protein and exposing a destabilizing Nt-residue in the
resulting C-terminal (Ct) fragment (37, 57, 69, 70, 74–80).
A different and mutually nonexclusive route to N-degrons is
through enzymatic Nt-modifications of proteins, including Nt-
acetylation, Nt-deamidation, Nt-arginylation, Nt-leucylation, or
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Nt-formylation of Nt-residues. Recognition components of N-degron
pathways, called N-recognins, are E3 Ub ligases or other proteins
(e.g., bacterial ClpS or mammalian p62) that can target specific
N-degrons (2, 15, 38). In cognate sequence contexts, all 20 amino
acids of the genetic code can act as destabilizing Nt-residues (2).
Consequently, a number of cellular proteins and their natural
Ct-fragments are either constitutively or conditionally short-
lived N-degron substrates. Some N-recognin E3s are able to rec-
ognize, through distinct binding sites, not only N-degrons but also
specific non–N-terminal degradation signals, thereby further
expanding the substrate range of N-degron pathways (2, 39).
Eukaryotic N-degron pathways comprise the Arg/N-degron
pathway (it recognizes, in particular, specific unacetylated Nt-
residues); the Ac/N-degron pathway (it recognizes, in particular,
the Nα-terminally acetylated [Nt-acetylated] Nt-residues); the
fMet/N-degron pathway (it recognizes Nt-formylated proteins);
and the Pro/N-degron pathway (it recognizes, in particular, the
Nt-proline [Pro] residue or a Pro at position 2, in the presence of
cognate adjoining sequence motifs) (2, 35, 38–42, 74). The latter
pathway is the main subject of this report (Fig. 1).
Regulated degradation of proteins and their natural fragments
by N-degron pathways has been shown to mediate a multitude of
processes, including the sensing of heme, oxygen, and nitric ox-
ide; the control of subunit stoichiometries in protein complexes;
selective elimination of misfolded proteins and of proteins ret-
rotranslocated to the cytosol from other compartments; re-
pression of neurodegeneration and regulation of either apoptosis
or other pathways of programmed cell death; regulation of DNA
repair, transcription, replication, and chromosome cohesion/
segregation; regulation of chaperones, G proteins, cytoskeletal
proteins, autophagy, gluconeogenesis, peptide import, meiosis,
circadian rhythms, fat metabolism, cell migration, immunity
(including inflammation), cardiovascular system, spermatogene-
sis, and neurogenesis; and regulation of many processes in plants
(refs. 2, 22, 35, 37–45, 49–74, and 81 and references therein).
To keep notations uniform, human genetic terms (all-uppercase
letters) are used below to denote both human and yeast (Sac-
charomyces cerevisiae) genes and proteins. Under conditions of
low or absent glucose, cells can synthesize it through gluconeo-
genesis. In S. cerevisiae, the main gluconeogenesis-specific cyto-
solic enzymes are the FBP1 fructose-1,6-bisphosphatase, the ICL1
isocitrate lyase, the MDH2 malate dehydrogenase, and the PCK1
phosphoenolpyruvate carboxykinase (43, 74, 82–95). When S.
cerevisiae grows on a nonfermentable carbon source such as, for
example, ethanol, gluconeogenic enzymes are expressed and long-
lived. A shift to a medium containing glucose inhibits the synthesis
of these enzymes and induces their degradation. Degradation of
yeast gluconeogenic enzymes requires the multisubunit GID Ub
ligase (74, 86, 87, 90, 96, 97). The ∼600-kDa GID comprises at
least the GID1, GID2, GID4, GID5, GID7, GID8, GID9, and
GID10 subunits, as well as the weakly associated Ub-conjugating
(E2) enzyme UBC8 (GID3) (43, 44, 46, 47, 86, 96). GID10 is
expressed only during some stresses (47).
A notable aspect of GID-mediated processes is the dichotomy
between the GID/proteasome-mediated degradation of gluco-
neogenic enzymes and their “alternative” degradation through an
autophagy-related pathway called vacuolar import and degrada-
tion (VID) (87, 90, 93, 95, 98–100). The VID pathway may also
involve a GID-mediated polyubiquitylation of gluconeogenic en-
zymes. Whether these enzymes are destroyed (after a return of
cells to glucose-containing media) largely by the GID/proteasome
pathway or largely by the VID pathway depends, among other
things, on the duration of glucose starvation and the nature of a
nonglucose carbon source (84, 101). The function of this di-
chotomy, the regulation of transitions between the GID/protea-
some and VID pathways, and molecular mechanisms of VID
remain to be understood (43, 96).
S. cerevisiae GID4 is a 41-kDa subunit of GID (43, 44, 97).
Chen et al. and Melnikov et al. have shown that GID4 and
(stress-inducible) GID10 are N-recognin subunits of the GID
Ub ligase that mediates the Pro/N-degron pathway (Fig. 1)
(2, 43–47). GID4, the main N-recognin of this pathway, binds to
protein substrates through their Nt-Pro residue or a Pro at po-
sition 2 in the also required presence of adjoining sequence
motifs (43–46). S. cerevisiae gluconeogenic enzymes bear either
Nt-Pro (FBP1, ICL1, MDH2) or a Pro at position 2 (PCK1).
These enzymes are conditionally short-lived substrates of the
Pro/N-degron pathway (Fig. 1) (43, 45, 97). Dong et al. (44)
determined the crystal structure of human GID4, which com-
prises an antiparallel β-barrel that contains a substrate-binding
cleft (44–46). Qiao et al. (46) employed cryoelectron microscopy
and other methods to characterize the entire GID Ub ligase,
revealing its overall shape and also, in particular, specific inter-
actions between its N-recognin subunit GID4 and the rest of
GID. In mammals, the GID Ub ligase (it is also called CTLH)
functions in primary cilia, in cell proliferation, and in other
processes (96, 102–110).
Here we show that human GID4 (in the presence of cognate
downstream motifs) can recognize not only the Nt-Pro residue
but other specific hydrophobic Nt-residues as well. We solved
crystal structures of human GID4 bound to a peptide bearing
either Nt-Ile or Nt-Val. We also used site-directed mutagenesis
of GID4 to analyze the roles of GID4 residues in the binding of
substrates by this N-recognin. These approaches determined
relative contributions of specific GID4 residues to the GID4-
mediated recognition of Nt-Pro versus Nt-residues other than
Pro. We also show that S. cerevisiae GID4 can target a protein
bearing a Pro-lacking Nt-sequence, such as Nt-IGLW, for rapid
degradation by the Pro/N-degron pathway. These and related
results advanced the understanding of GID4 N-recognin and
expanded the substrate recognition range of the Pro/N-degron
pathway in both human and yeast cells.
Results and Discussion
GID4 Can Recognize Nt-Sequence Motifs Lacking Pro. GID4, a sub-
unit of the GID Ub ligase and the main N-recognin of the Pro/
N-degron pathway, has been shown to recognize (specifically
bind to), both in vitro and in vivo, protein substrates that contain
the Nt-Pro residue or a Pro at position 2, in the also required
presence of cognate adjoining sequence motifs (Fig. 1) (43–45).
For example, in vivo yeast-based two-hybrid (Y2H) binding as-
says could detect the binding of S. cerevisiae GID4 to the Nt-
Pro–bearing gluconeogenic enzyme Pro-FBP1 but not to its
otherwise identical Nt-Ser–bearing mutant Ser-FBP1 (43). This
recognition specificity of GID4 underlied the GID4-dependent
in vivo degradation of Pro-FBP1, in contrast to metabolic sta-
bility of Ser-FBP1 (43). Yeast GID4 was also found to bind, in
Fig. 1. The S. cerevisiae Pro/N-degron pathway. The diagram shows both
GID4, the pathway’s main N-recognin, and GID10, a stress-inducible and
functionally minor N-recognin (see Introduction and references therein).
Findings of the present study demonstrated, in particular, the ability of both
human and S. cerevisiae GID4 to recognize, in peptide-sized polypeptides
bearing cognate adjoining motifs, not only Nt-Pro but also Nt-Ile, Nt-Leu,
Nt-Val, and Nt-Phe. In addition, the S. cerevisiae Pro/N-degron pathway
was found to target a test protein bearing the Nt-Ile–containing sequence
IGLW for rapid degradation that required GID4 (Results).
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Y2H assays, to the Nt-sequence SPSV, which contained a Pro at
position 2. That Nt-sequence was identical to the Nt-sequence
SPSK of the short-lived S. cerevisiae gluconeogenic enzyme
PCK1 (an in vivo substrate of GID4), save for the presence of
Val, instead of Lys, at position 4 of SPSV (43).
Crystal structures of human GID4 bound to different Nt-
Pro–containing short peptides showed that the main-chain
α-imino group of Nt-Pro in these peptides is coordinated by
five GID4-mediated hydrogen bonds, while the pyrrolidine side
chain of Pro is bound to a hydrophobic patch in GID4 (44). It
seemed possible that the pyrrolidine-contacting hydrophobic
pocket of GID4 might tolerate some hydrophobic residues other
than Pro. To address this conjecture, we used a mutation-
scanning peptide SPOT array to characterize the substrate
specificity of human GID4. Each residue of the PGLVKSAS
peptide was substituted, systematically, with 1 of 18 amino acids
of the genetic code, save for Cys and Trp, because of difficulties
in using the latter residues to synthesize SPOT peptides. The
array was incubated with full-length human GID4 N-terminally
tagged with glutathione transferase (GST), and the binding of
GID4 to peptide spots was detected using antibody to GST and
chemilumenescence (Fig. 2).
We found that several hydrophobic residues (Ile, Leu, Val,
and Phe) could substitute for Nt-Pro in the above SPOT se-
quence without eliminating the binding of resulting peptides to
human GID4 (Fig. 2). In agreement with previous evidence (44),
the binding of GID4 was stronger if a small side-chain residue
was present at position 2. In addition, no significant binding of
GID4 was observed with peptides bearing Gly, Asp, or Pro at
position 3. GID4 exhibited at most a minor dependence of its
binding to array’s peptides beyond position 3 (Fig. 2).
To further analyze these binding patterns, we synthesized a set of
six-residue peptides (XGLWKS; X = any Nt-residue), and used an
isothermal titration calorimetry (ITC) binding assay to quantify
their interactions with the binding-competent GID4116−300 fragment
of the full-length human GID41−300 (44) (Fig. 3). Since the binding
of XGLVKSAS peptides by GID4 did not exhibit a significant se-
quence specificity beyond position 3 (Fig. 2), the four-residue
XGLW was extended by the Lys-Ser (KS) Ct-sequence to in-
crease solubility of peptides that were used in ITC binding assays.
In agreement with SPOT-array data (Fig. 2), GID4116−300
exhibited significant affinities for the XGLWKS peptides in
which X was either Ile (Kd of 16 μM), Leu (Kd of 21 μM), Val (Kd
of 36 μM), or Phe (Kd of 40 μM). The affinity of GID4116−300 for
the otherwise identical but Nt-Pro–bearing PGLWKS (Kd of 1.9
μM) was still significantly stronger than for the other four pep-
tides (Fig. 3 and SI Appendix, Fig. S1). While the binding of
GID4116−300 to the Nt-Met–bearing sequence MGLWKS could
still be detected by ITC, the binding affinity (Kd of 72 μM) was
even lower than the affinity of GID4116−300 for the FGLWKS
peptide (Figs. 1 and 3 and SI Appendix, Fig. S1).
Unexpectedly, we found that GID4116−300 had a relatively high
affinity (Kd of 7 μM) for the Nt-Cys–bearing CGLWKS peptide
(SI Appendix, Fig. S2A). Inasmuch as there was no detectable
binding of GID4116−300 to the SGLWKS peptide, whose Nt-Ser is
sterically and chemically similar to Nt-Cys (Fig. 3), we suspected
that the binding to CGLWKS may have been artifactually
strengthened by the formation of a disulfide bond between Nt-
Cys of CGLWKS and a Cys residue of GID4116−300. In the 3D
crystal structure of GID4 (44), one of two Cys solvent-exposed
residues, Cys-156 and Cys-261, might be involved in the disulfide
bond formation with Nt-Cys of CGLWKS (SI Appendix, Fig.
S2 D–F). To address this possibility, we constructed a human
GID4116−300 mutant in which these two cysteines were converted to
Ser. In agreement with our assumption, the GID4116−300, C156S, C261S
mutant retained a nearly wild-type (high) affinity for the Nt-Pro–
bearing PGLWKS peptide but did not exhibit a detectable binding
to the CGLWKS peptide (SI Appendix, Fig. S2). In sum and for
the reasons above, an Nt-Cys–bearing polypeptide is unlikely to be
a physiologically relevant GID4 ligand.
Structural Basis for the Binding of Human GID4 to Non-Pro Nt-Residues.
To address molecular basis of the GID4-mediated recognition of
Nt-sequences that bear non-Pro Nt-residues, we determined high-
resolution crystal structures of human GID4124−289 in complexes
with the six-residue peptides IGLWKS and VGLWKS, re-
spectively (Figs. 4 and 5A; see SI Appendix, Table S1 for crystal
diffraction data and model refinement statistics). Detailed com-
parisons showed that the structures of GID4124−289-IGLWKS and
GID4124−289-VGLWKS are very similar to that of GID4124−289-
PGLWKS, with backbone RMSDs of less than 0.5 Å (Fig. 4).
The α-amino groups of the above non–Nt-Pro peptides are
coordinated by a set of conserved hydrogen bonds, similar to the
set that coordinates the Nt–α-imino group of the Nt-Pro peptide.
Specifically, the free α-amino group of Nt–Val-1 or Nt–Ile-1
forms hydrogen bonds with the side chains of Glu-237 and
Tyr-258 of GID4, while the carbonyl oxygen of Val-1 or Ile-1 is
further stabilized, through another hydrogen bond, by Gln-132 of
GID4. The main chain of the second residue (Gly-2) of the six-
residue peptides is anchored by the main chain of Ser-253 via two
hydrogen bonds. The main chain of the third residue (Leu-3) of a
bound peptide forms two hydrogen bonds with the side chain of
Gln-282. Trp-4, the fourth residue of these peptides, interacts,
through a hydrogen bond, with Gly-251 of GID4 (Figs. 4 and
5A). Inasmuch as bound peptides are located in the nearly
enclosed binding channel of GID4, and since the first (Nt) res-
idue of a peptide is deeply buried in the channel’s narrow end,
the Pro residue is preferred, affinity-wise, as the Nt-residue of a
GID4 substrate. But the binding cavity is still large enough to
accommodate some other hydrophobic residues, such as Ile or
Val. In this cavity of GID4, the side chain of a peptide’s Nt-
residue is surrounded by the hydrophobic residues L159, V141,
I161, L164, L171, I249, L240, and F254 (Figs. 4 and 5A).
Use of GID4 Mutants to Analyze Binding Specificity of GID4.We used
site-directed mutagenesis to convert to Ala residues – specific
bulky hydrophobic residues of GID4 that surround the Nt-Ile
residue of the GID4-bound IGLWKS peptide. These single-
residue mutations caused a strong reduction of binding of the
IGLWKS peptide to a mutant GID4, or even the loss of de-
tectable binding (Fig. 5B and SI Appendix, Table S2).
Interestingly, an uncharged hydrophilic residue of GID4, Thr-
173, is located near the hydrophobic pocket that binds to a hydro-
phobic Nt-residue of a substrate (Fig. 5A). Because of its spatial
proximity to the hydrophobic pocket, Thr-173 might interfere with
the binding of Nt-Pro or other substrates’ hydrophobic Nt-residues
to wild-type GID4. To address this possibility, Thr-173 of GID4 was
replaced with single hydrophobic residues, such as Ala, Val, Leu,
and Ile. In agreement with the above prediction, all of these
position-173 mutants bound to the IGLWKS peptide with a higher
affinity than wild-type GID4. For example, the GID4T173A mutant
bound to IGLWKS fourfold more tightly than did wild-type GID4
(Fig. 5C and SI Appendix, Table S3). The results were similar with
the binding of position-173 GID4 mutants to the otherwise identical
but Nt-Pro–bearing PGLWKS, except that the strongest binder was
the GID4T173V mutant, in contrast to GID4T173A vis-à-vis IGLWKS
(Fig. 5 C and D). On the assumption (to be verified) that the in-
creased affinity exhibited by some GID4 derivatives altered at
position-173 is not accompanied by a lowered specificity of binding,
such mutants may prove particularly helpful in screens for physio-
logical substrates of the Pro/N-degron pathway.
GID4-Dependent Degradation of a Protein Bearing the Nt-Ile Residue.
Previous work has shown that the S. cerevisiae and human
GID4 N-recognins are not only sequelogous [similar in sequence
(111)] and contain the above-described hydrophobic binding
Dong et al. PNAS Latest Articles | 3 of 10
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chamber (Figs. 4 and 5A), but are also similar in their recogni-
tion specificities vis-à-vis test proteins that bear, in particular, Nt-
Pro (43, 44, 47, 48). We asked, therefore, whether S. cerevisiae
GID4 may also, similarly to human GID4, recognize a non-Pro
Nt-residue of a protein and in addition target that protein for the
in vivo degradation by the Pro/N-degron pathway.
Protein degradation was assayed in yeast using the promoter
reference technique (PRT) (74). In this method, both a protein
of interest and a long-lived reference protein (dihydrofolate re-
ductase, DHFR) are expressed in S. cerevisiae from the same
plasmid and identical constitutive promoters that contain addi-
tional (PRT-specific) DNA elements. Once transcribed, these
elements form specific 5′-RNA aptamers that can bind to the
added (cell-penetrating) tetracycline (Tc). As a result, Tc, which
does not inhibit global translation in the cytosol, can selectively
repress translation of the aptamer-containing mRNAs that en-
code both the reference and test proteins (74). Advantages of
PRT include the accuracy-increasing reference protein and the
avoidance of cytotoxic, artifact-prone global translation inhibi-
tors, such as cycloheximide in chase-degradation assays (74).
Following the addition of Tc, a decrease in the amount of a test
protein relative to the reference protein during a chase would
signify degradation of the test protein.
We used PRT to ask whether yeast GID4 could target for
degradation a test protein that comprises the C-terminally triple-
flagged S. cerevisiae FBP13f gluconeogenic enzyme in which the
Nt-Pro–bearing (and targetable by GID4) Nt-sequence PTLV
(43) was replaced by Nt-IGLW. The latter has been identified as
the Nt-sequence that could bind to human GID4 in vitro with a
significant affinity (Kd of 16 μM) (Fig. 3 and SI Appendix, Fig.
S1B). That affinity was, however, not as high as the affinity of the
otherwise identical Nt-Pro–bearing Nt-sequence PGLW (Kd of
1.9 μM) (Fig. 3 and SI Appendix, Fig. S1A).
The initially present Nt-Met residue of a test protein is
cotranslationally cleaved off by ribosome-associated MetAPs if a
residue at position 2 (it would become N terminal after cleavage)
is not larger than Val (2, 112). For example, the Pro residue at
position 2 does not impede the MetAP-mediated removal of the
initially present Nt-Met, a step that yields Nt-Pro (2, 112). In
contrast, Nt-Ile, the Nt-residue of the human GID4-binding
IGLW peptide, is larger than Val, and therefore would not be-
come N terminal if Ile follows Nt-Met in a nascent polypeptide.
The Ub fusion technique bypasses this problem by making it
possible to expose, in vivo, any desired residue (except Pro) at
the mature N terminus of a protein of interest (113). In this
method, a protein is expressed as a linear Ub-X–protein fusion.
The fusion’s Ub moiety is cotranslationally cleaved off by a
family of deubiquitylating enzymes (present in all eukaryotes),
yielding X-protein that bears the desired Nt-X residue (113).
S. cerevisiae cells carrying a PRT-based plasmid that expressed
the 187-residue DHFR reference protein (tagged with both flag
and ha epitopes) and a test protein—either Ub-MPTLV-FBP13f,
Ub-MSTLV-FBP13f, Ub-IGLW-FBP13f, or Ub-MPGLW-FBP13f
(43)—were grown in a glucose-containing minimal medium. In
this setting, PTLV becomes the Nt-sequence of wild-type FBP1
after the cotranslational removal of its Nt-Met by MetAPs.
Fig. 2. Use of peptide arrays to analyze substrate recognition by human GID4. (A) Binding patterns of the full-length human GID4 to an array of the spotted
Nt-Pro–bearing peptide PGLVKASAS (top row, denoted “wild-type” [wt]) and its indicated derivatives (Materials and Methods). (B) The array binding data
were quantified and the relative binding of GID4 to each peptide is shown, with strong to weak binding scaled from black to white. (C) These substrate
preferences of GID4 are also shown as a sequence logo.
4 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.2007085117 Dong et al.
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Because of the removal of Nt-Met, both theMPTLV-FBP13f and
MSTLV-FBP13f moieties of the above Ub fusions were present
in vivo as the short-lived wild-type PTLV-FBP13f (derived from
MPTLV-FBP13f) and the otherwise identical but long-lived STLV-
FBP13f (derived fromMSTLV-FBP13f) (43). The Nt-Ser residue is
not recognized by GID4, in contrast to Nt-Pro (43, 44). The above
Ub fusion-based versions of MPTLV-FBP13f and MSTLV-FBP13f
served as controls, to verify the suitability of using the Ub fusion
technique (113) to assay GID4 substrates for degradation by the
Pro/N-degron pathway.
The in vivo translation of both a test protein and the DHFR
reference was selectively repressed by the addition of Tc, thereby
initiating a chase (74). As expected, PTLV-FBP13f (but not
STLV-FBP13f) was short-lived in vivo. Degradation of PTLV-
FBP13f required GID4, as no degradation was observed in gid4Δ
cells (Fig. 6 C and D). Ub-MPGLW-FBP13f (becoming PGLW-
FBP13f in vivo), whose Nt-Pro–bearing sequence PGLW could
bind to GID4 in vitro (Figs. 2 and 3 and SI Appendix, Fig. S1A),
was also short-lived in vivo, in a GID4-dependent manner
(Fig. 6 A and B).
The IGLW-FBP13f protein (it became IGLW-FBP13f after the
in vivo removal of Nt-Ub by DUBs), whose Nt-Ile–bearing Nt-
sequence IGLW could bind to GID4 in vitro (Fig. 3 and SI
Appendix, Fig. S1 B and G), was also short-lived in vivo (Fig. 6 A
and B). The degradation of both PGLW-FBP13f and IGLW-
FBP13f required GID4, as this degradation did not occur in gid4Δ
cells (Fig. 6 A and B). Thus, the Pro-lacking Nt-sequence IGLW
not only binds to GID4 but can also confer, on a test protein,
a GID4-dependent degradation in S. cerevisiae (Figs. 3 and
6 A and B).
Fig. 3. Affinities (Kds) of XGLWKS peptides for the GID4
116–300 fragment of
the full-length human GID41–300 (44). NDB, no detectable binding to
GID4116–300 (Kd > 0.5 mM). Superscript “a” (
a) signifies ITC measurements
with CGLWKS performed using a cysteine-deficient mutant of GID4116–300
(Materials and Methods and SI Appendix, Fig. S2).
Fig. 4. Structural basis of recognition of nonproline N-terminal residues by
human GID4. (A) Superposition, in ribbon diagrams, of the overall crystal
structures of complexes of GID4124–289 with, respectively, PGLWKS (salmon,
PDB ID code 6CDG), VGLWKS (green), and IGLWKS (cyan) peptides (see also
Materials and Methods and SI Appendix, Table S1). (B) Close-up view of
similar (conserved) interactions between the substrate-binding chamber of
GID4 and the first four residues of the above peptides (PGLW, salmon;
VGLW, green; and IGLW, cyan). The most relevant residues of GID4 are
shown as gray/red/blue sticks vis-à-vis colored peptides. Hydrogen bonds are
indicated as black dash lines. (C) Close-up view of the recognition of the Nt-
Ile–bearing IGLWKS peptide in the substrate-binding chamber of human
GID4. Denoted in red are the first four residues of the six-residue peptide.
These residues are depicted as cyan/red/blue sticks. The most relevant resi-
dues of the GID4 chamber are either in black or in green (the hydrophilic
Thr-173 residue), and are depicted via surface representations and
gray sticks.
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Interestingly, the GID4-dependent degradation of IGLW-
FBP13f not only occurred but was even faster than the degra-
dation of PGLW-FBP13f, although the in vitro affinity of human
GID4 for the Nt-sequence IGLW (Kd of 16 μM) is significantly
lower than the affinity of GID4 for the otherwise identical but
Nt-Pro–bearing sequence PGLW (Kd of 1.9 μM) (Figs. 3 and 6 A
and B and SI Appendix, Fig. S1 A, B, and G). Moreover, the
early, prechase [“time-zero” (2, 35)] degradation of IGLW-
FBP13f was also greater than the analogous degradation of
PGLW-FBP13f (Fig. 6 A and B). Detailed reasons for the in vivo
degradation of PGLW-FBP13f being slower than that of IGLW-
FBP13f, despite the converse order of their in vitro affinities for
GID4 remain to be understood. A plausible interpretation of
these findings is as follows. Only one cotranslational in vivo
cleavage (removal of the Nt-Ub moiety by DUBs) is required to
produce the GID4-targetable IGLW-FBP13f protein from Ub-
IGLW-FBP13f. In contrast, two obligatorily sequential cleavage
steps, the removal of the Nt-Ub moiety and the removal of
resulting Nt-Met by MetAPs, are required to produce the GID4-
targetable PGLW-FBP13f protein from Ub-MPGLW-FBP13f.
The resulting additional delay in generating PGLW-FBP13f (in
contrast to no such delay in generating IGLW-FBP13f) may lead
to a slower or incomplete removal of Nt-Met from MPGLW-
FBP13f, the immediate precursor of PGLW-FBP13f.
In vivo levels of ribosome-associated MetAPs are significantly
higher in the immediate vicinities of ribosomes than in the bulk
solution. It is likely, therefore, that the two-step production of
PGLW-FBP13f from the Ub-MPGLW-FBP13f is significantly less
efficacious than the one-step (and MetAP-independent) pro-
duction of IGLW-FBP13f from the Ub-IGLW-FBP13f. One likely
reason for this inefficiency is that the N terminus of a nascent
(being made) protein keeps moving away from a translating ri-
bosome into bulk-solution regions that contain lower levels
of MetAPs.
This model, to be addressed in future studies, predicts that the
GID4-dependent degradation of PGLW-FBP13f that is pro-
duced, in one step, from MPGLW-FBP13f (Nt-Met can be
cotranslationally removed if position 2 is occupied by Pro) would
be faster than the degradation of the otherwise identical PGLW-
FBP13f that is produced from Ub-MPGLW-FBP13f through the
above two-step reaction. The degradation of PGLW-FBP13f that
is produced through a single cleavage step is also predicted to be
faster than the degradation of IGLW-FBP13f (which is produced
from Ub-IGLW-FBP13f by DUBs), because of the difference in
binding affinities of GID4 for Nt-PGLW vs. Nt-IGLW (Fig. 3
and SI Appendix, Fig. S1 A, B, and G).
Concluding Remarks. We have shown that in the presence of
cognate downstream motifs, human GID4, the main recognin of
the Pro/N-degron pathway, can recognize not only the Nt-Pro
residue but a few other hydrophobic Nt-residues as well (Figs.
1–3 and SI Appendix, Fig. S1). We solved crystal structures of
human GID4 bound to peptides that bear either Nt-Ile or Nt-Val
(Figs. 4 and 5A). We also used site-directed mutagenesis of
GID4 to analyze the roles of GID4 residues in the binding of
substrates by this N-recognin (Fig. 5 and SI Appendix, Tables S2
and S3). These approaches determined contributions of specific
GID4 residues to the GID4-mediated recognition of the Nt-Pro
residue versus hydrophobic residues other than Pro. We also
found that the S. cerevisiae GID4 N-recognin can target a protein
bearing an Nt-sequence, such as Nt-IGLW (which lacks both Nt-
Pro and a Pro at position 2) for rapid degradation by the Pro/
N-degron pathway in vivo (Fig. 6).
The Nt-Ile residue of the sequence such as Nt-IGLW can be
recognized as a destabilizing one not only by GID4 of the Pro/
N-degron pathway but also, for example, by S. cerevisiae UBR1,
the N-recognin of the yeast Arg/N-degron pathway, except that
Nt-Ile binds to UBR1 less strongly than other UBR1-recognized
destabilizing Nt-residues (2). With that caveat, it is possible that
some proteins (or protein fragments, since Nt-Ile would not be
normally exposed at a nascent protein’s N terminus; see above)
might be targetable, independently, by both the Pro/N-degron
and Arg/N-degron pathways.
The known physiological substrates of the S. cerevisiae Pro/
N-degron pathway are the gluconeogenic enzymes FBP1, ICL1,
MDH2, and PCK1. All four of these proteins are conditionally
polyubiquitylated and destroyed by the S. cerevisiae GID Ub li-
gase and the proteasome (Introduction). The GID ligase targets
FBP1, ICL1, MDH2, and PCK1 via GID4, the main N-recognin
of GID that binds to Nt-Pro residues (in FBP1, ICL1, and
MDH2) or to a Pro at position 2 (in PCK1), in the also required
presence of adjoining motifs (2, 43–45, 48, 96).
The S. cerevisiae genome encodes about 300 proteins that are
expected to bear Nt-Pro (43). However, at least a majority of these
proteins do not appear to be substrates of GID4 N-recognin, in
contrast to FBP1, ICL1, and MDH2 (43, 47, 48). In addition, it
remains to be determined whether there are physiological
Fig. 5. (A) Plot of affinities (relative association constants, Kas) of the Nt-
Ile–bearing peptide IGLWKS for GID4116–300 and its indicated single-residue
mutants, with the affinity of wild-type GID4116–300 for IGLWKS taken as
100%. NDB, no detectable binding (Kd > 0.5 mM). (B) Plot of affinities (rel-
ative association constants, Kas) of the Nt-Ile–bearing peptide IGLWKS for
GID4116–300 and its indicated position-173 mutants, with the affinity of wild-
type GID4116–300 for IGLWKS taken as 100%. (C) Plot of affinities (relative
association constants, Kas) of the Nt-Pro–bearing peptide PGLWKS for
GID4116–300 and its indicated position-173 mutants, with the affinity of wild-
type GID4116–300 for PGLWKS taken as 100%. In B and C, the highest-affinity
levels for position-173 GID4 mutants (they differ for the IGLWKS versus
PGLWKS peptides) are highlighted in red.
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substrates of S. cerevisiae GID4 other than PCK1 that are tar-
geted, at least in part, through their Pro at position 2, analogously
to PCK1.
In vertebrates, including mammals, the GID (CTLH) Ub li-
gase functions in primary cilia, in cell proliferation, and in other
processes, including apparently, glucose sensing and energy ho-
meostasis (refs. 96 and 102–110 and references therein). While
the Pro residue at position 2 is strongly conserved among both
fungal and vertebrate PCK1 enzymes, the Nt-Pro residues of S.
cerevisiae FBP1, ICL1, and MDH2 are weakly conserved even
among fungi, and are absent, for example, from mammalian
counterparts of these enzymes. In addition, the mammalian
versions of S. cerevisiae FBP1, ICL1, and MDH2 are apparently
not targeted for degradation by the GID (CTLH) Ub ligase (refs.
96 and 102–110 and references. therein).
In sum, little is known about physiological substrates of S.
cerevisiae GID4 outside the set of yeast gluconeogenic enzymes
(Fig. 1) (43, 47, 48). As to human GID4, its Nt-Pro–bearing
physiological substrates remain to be identified (44). It is also
unknown whether some non-GID4 main subunits of the GID Ub
ligase (Introduction) might also function as its targeting com-
ponents (of currently unknown specificity), in addition to and
independently of GID4.
One ramification of results in the present study is that they will
facilitate discovery of physiological substrates of the Pro/N-degron
pathway, since potential GID4 substrates are no longer confined
to proteins that bear Nt-Pro or a Pro at position 2. In addition, our
findings deepened the previously revealed similarity of target
recognition by the S. cerevisiae and human GID4 N-recognins
by expanding their substrate range from interactions with Nt-Pro
or a Pro at position 2 to their demonstrated interactions, in a
functionally relevant manner, with specific Nt-residues other
than Pro (Figs. 1–6).
Materials and Methods
Antibodies and Other Reagents. The following primary antibodies were used
for immunoblotting: Antihemagglutinin (ha) tag monoclonal antibody
(Sigma, H6908) and anti-flag M2 monoclonal antibody (Sigma, F1804). Sec-
ondary antibodies for immunoblotting were Li-Cor IRDye-conjugated goat
anti-rabbit 680RD (Li-Cor, C51104-08) or anti-mouse 800CW (Li-Cor,
#C60405-05). Fluorescence was detected and quantified using Odyssey 9120
(Li-Cor). The UltraCruz protease inhibitor mixture tablet (EDTA-free) was
from Santa Cruz Biotechnology. A variety of restriction enzymes (used for
plasmid construction), T4 DNA ligase, and Q5 DNA polymerase were from
New England Biolabs. Tc and glucose were from Sigma. Short synthetic
peptides used in this study were produced by Apeptide Co.
Yeast Strains and Media. The S. cerevisiae strains used in this study were
BY4741 (MATa his3Δ1 leu2Δ met15Δ ura3Δ) and BY3244 (gid4Δ derivative
of BY4741). Standard techniques were used for constructing plasmids and
yeast strains (114, 115). Yeast media included YPD medium (1% yeast ex-
tract, 2% peptone, 2% glucose); SC medium (0.17% yeast nitrogen base,
0.5% ammonium sulfate, 2% glucose, supplemented with compounds
required by auxotrophic yeast strains); SE medium (the same as SC but with
2% ethanol instead of glucose). Yeast nitrogen base with ammonium
sulfate as well as supplement mixtures of amino acids for S. cerevisiae
growth were from MP Biomedicals. Yeast extract and yeast peptone were
from Difco.
Cloning, Expression, and Purification of Human GID4. DNA sequence encoding
the full-length human GID4 was amplified by PCR from the human mam-
malian gene collection of cDNA clones (Open Biosystems), and was cloned
into pET28GST-LIC vector encoding a GST tag at the N terminus. After
transformation of the resulting plasmid into Escherichia coli BL21 (DE3), cells
Fig. 6. A protein bearing the GID4-binding, Prolacking N-terminal sequence Nt-IGLW can be targeted by the S. cerevisiae Pro/N-degron pathway for GID4-
dependent degradation. The bands of test and reference (DHFR) proteins are indicated on the left. (A) Lane 1, kilodalton marker. Lanes 2 to 5, Tc/PRT-initiated
chase assay (Results) with Ub-MPGLW-Fbp1f3 in wild-type S. cerevisiae. Lanes 6 to 9, same as in lanes 2 to 5, but with gid4Δ cells. Lanes 10 to 13, same as in
lanes 2 to 5, but with Ub-IGLW-Fbp1f3. Lanes 14 to 17, same as in lanes 6 to 9 (gid4Δ cells) but with Ub-IGLW-Fbp1f3. (B) Quantification of data in A. Identities
of specific curves are indicated below lane numbers. (C) Lanes 1 to 4, Tc/PRT-chase assay with Ub-MPTLV-Fbp1f3 in wild-type S. cerevisiae. Lanes 5 to 8, same as
in lanes 1 to 4 but with gid4Δ cells. Lanes 9 to 12, same as lanes 1 to 4 but with Ub-MSTLV-Fbp1f3. Lanes 13 to 16, same as lanes 5 to 8 (gid4Δ cells), but with Ub-
MSTLV-Fbp1f3. (D) Quantification of data in C. Identities of specific curves are indicated below lane numbers. All degradation assays were performed at least
twice, yielding results that differed by less than 10%.
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were grown in Terrific Broth (TB) medium (Sigma-Aldrich) at 37 °C until
OD600 of 1.0 and induced with a final concentration of 0.3 mM isopropyl
β-D-1-thiogalactopyranoside (IPTG) for protein expression at 16 °C over-
night. Cells were harvested by centrifugation, the pellet was resuspended
in lysis buffer (0. 5M NaCl, 5% glycerol, 2 mM β-mercaptoethanol, 20 mM
Tris·HCl pH 7.5), and cells were disrupted by sonication. The resulting
sample was centrifuged at 12,000 × g for 1 h at 4 °C. The supernatant was
loaded onto a glutathione-Sepharose column and washed with lysis
buffer. The GID4 protein was eluted with 10 mM glutathione and further
purified by gel filtration on Superdex 200 column (GE Healthcare).
GID4124−289 and other relevant mutants were expressed and purified as
described previously (44).
Protein Crystallization. Crystallization experiments were performed at 18 °C
using sitting-drop vapor-diffusion method, by mixing 1 μL of protein so-
lution and 1 μL of reservoir solution. Prior to setting up crystallization
trials, purified human GID4124−289 was incubated with the IGLWKS or the
VGLWKS peptide for 1 h on ice at a molar ratio of 1:1.5. Crystals of the
GID4-IGLWKS complex were obtained in the crystallization buffer (20%
[wt/vol] polyethylene glycol [PEG]-3350 and 8% [vol/vol] Tacsimate,
[Hampton Research], pH 7.0). Crystals of the GID4-VGLWKS complex were
obtained in 20% (wt/vol) PEG-3350, 0.03 M citrate, pH 7.6. The crystals
were cryoprotected by adding 20% (vol/vol) glycerol to the reservoir,
followed by flash-cooling in liquid N2 and storage in liquid N2 until data
collection.
Data Collection and Structure Determination. Diffraction images of GID4
crystals containing the complexes GID4-IGLWKS or GID4-VGLWKS where
collected at Advanced Photon Source beam line 24-ID-E and Canadian Light
Source beam line 08ID, respectively, and processed using XDS (116) and
AIMLESS programs (117). The structures were solved by molecular re-
placement with the program PHASER (118) and coordinates from an early
model of PDB ID code 6CCR (44). The models were refined with REFMAC
(119) and rebuilt with COOT (120).
Isothermal Titration Calorimetry. ITC measurements were carried out at 25 °C
using VP-ITC instrument (Microcal). Purified proteins and peptides were
prepared in the titration buffer containing 0.1 M NaCl, 0.5 mM TECP [Tris (2-
carboxyethyl) phosphine], 20 mM Tris·HCl, pH 7.5. For a typical experiment, 1
to 2 mM of peptide solution was titrated into 50 to 100 μM of protein so-
lution with 26 injections of 10 μL each spaced by 180 s, and with a reference
power of 15 μ cal/s. ITC data were analyzed using a one-site binding model
and Origin 7.0 program (OriginLab).
Tc/PRT Chase-Degradation Assays. For quantifying the in vivo degradation of
specific proteins in S. cerevisiae, we used the Tc-based PRT (Tc/PRT) (Results)
(43, 47, 63, 74). Plasmids for these assays used pJO629 as the parental plas-
mid and were constructed as described previously (74). The pCSJ982 plasmid
expressed, in S. cerevisiae from the PTDH3-based promoter, the C-terminally
triple-flagged Ub fusion Ub-MPGLW-Fbp13f, in which the wild-type MPTLV
N-terminal sequence of Fbp1 was replaced by MPGLW. Briefly, to construct
pCSJ982, a Ub-MPGLW-Fbp13f–encoding DNA fragment was amplified by a
two-step PCR from S. cerevisiae genomic DNA and pBW227 (a Ub-encoding
plasmid), using, initially, the primers CSJ800 (5′-ATATATGGCGCGCCATGC
AGATCTTTGTGAAGAC-3′) and CSJ1021 (5′-CA AACCCTTCGGTAGAGTCTCTT
CTTGGTCCATTCCACAAACCTGG-CATACCACCGCGGAGGCGCAACAC-3′), and
thereafter the primers CSJ800 and CSJ182 (5′-ATATATGCGGCC GCTTACTTG
TCATCGTCATCCTTGTAATCGATATCAT-GATCTTTATAATCACCGTC-3′). The result-
ing PCR-produced DNA fragment was digested with AscI/NotI and ligated
into AscI/NotI-cut pJO629 downstream of its PTDH3-based promoter, yielding
pCSJ982. To alter the N-terminal sequence of Fbp1 in the Ub fusion proteins
of the above design, the same protocol was used, but different primer sets
for the first-round PCR. Specific first-round PCR reactions used different
primer sets, the primers CSJ800 and CSJ1023 (5′-CAAACCCTTC GGTAGAGTC
TCTTCTTGGTCCATTCCACAAACCAAT-ACCACCGCGGAGGCGCAACAC-3′), the
primers CSJ800 and CSJ1024 (5′-GAGTCTCTTCTTGGTCCATTTACTAGAGTT
GG-CATACCACCGCGGAGGCGCAACAC-3′), or the primers CSJ800 and CSJ1025
(5′-GAGTCTCTTCTTGGTCCATTTACTAGAGTAGACATACCACCGCGGAGGCGCA-
ACAC-3′), followed by the same steps as above (second-step PCR and sub-
sequent procedures, including DNA ligation) to construct pCSJ984, which
expressed Ub-IGLW-Fbp13f, pCSJ985 (which expressed Ub-MPTLV-Fbp13f), and
pCSJ986 (which expressed Ub-MSTLV-Fbp13f). Additional details are available
upon request. All final constructs were verified by DNA sequencing.
Tc/PRT chase-degradation assays (74) were carried out as described in
Results. Briefly, batch yeast cultures were grown in SC medium overnight.
Cells were centrifuged at 11,200 × g for 1 min, washed once in prewarmed
PBS buffer, then resuspended in SE (ethanol as the carbon source) to OD600
of 0.5 and allowed cells to grow in the respective media for 20 h at 30 °C.
Cells were collected by centrifugation, resuspended in fresh SC to the
final OD600 of 1.0, with Tc at 0.5 mM, and the tube was incubated at
30 °C, with gentle rocking. At indicated time intervals (including the
beginning of incubation), equal-volume samples were collected, and
cells were pelleted by centrifugation. Cell pellets were resuspended in
1 mL of 1 M NaOH, and incubated at room temperature for 5 min. Cell
were again collected by centrifugation (at the top speed in a micro-
centrifuge for 1 min), and resuspended in 50 μL of buffer HU (8 M urea,
5% SDS, 1 mM EDTA, 0.1 M DTT, 0.005% bromophenol blue, 0.2 M Tris·
HCl, pH 6.8). These protein solutions were incubated at 70 °C for 10 min.
Samples were fractionated by SDS/PAGE on 4 to 12% NuPAGE Bis·Tris
gels with Mops running buffer (ThermoFisher), followed by immuno-
blotting, as described previously (57, 58, 63, 74), using anti-flag (1:2,000),
anti-myc (1:1,000), and anti-ha (1:2,000) antibodies, as well as a sec-
ondary antibody (or antibodies). Immunoblot patterns were imaged and
quantified using the Odyssey 9120 instrument (Li-Cor Biotechnologies),
its software, and manufacturer’s manual. All Tc/PRT chases in this study
were repeated at least twice (often thrice), with results differing by 10%
or less.
GID4 Binding Assays with Peptide Arrays. Peptide arrays were synthesized on
cellulose membrane using the SPOT synthesis method (121) and Autospot
Multipep system (Intavis). Each spot contained ∼9 nmols of peptide
(Autospot Reference Handbook, Intavis) and the successful synthesis of
peptides on the cellulose membrane was qualitatively confirmed by
bromophenol blue staining. A peptide array was blocked overnight at
5% milk-PBST solution at 4 °C, 1× PBST is 0.05% Tween 20, 0.14 M NaCl,
2.7 mM KCL, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.5). Thereafter the
membrane was washed three times for 5 min with, and the peptide array
was preincubated for 5 min in interaction buffer (10% glycerol, 0.1 M
KCl, 1 mM EDTA, 20 mM Hepes pH 7.5). The array was then incubated for
1 h at room temperature in the interaction buffer containing 50 nM GST-
tagged GID4. The membrane was washed three times for 5 min in 1×
PBST, followed by incubation 1 h at room temperature with the primary
antibody to GST (1:6,000, anti-GST, polyclonal; GE Healthcare, cat. no.
10595345). After repetition of the washing, the membrane was in-
cubated for 1 h at room temperature with secondary antibody (1:12,000,
anti-goat IgG [whole-molecule]-peroxidase antibody produced in rabbit;
Sigma-Aldrich, cat. No. A4174). The signal was detected by chem-
ilumenescence using a Hyperfilm TM high-performance autoradiography
film (GE Healthcare). GID4 binding assays were carried out twice. The
data were normalized and the average binding of GID4 to each peptide
was calculated. SDs of the spot intensities were calculated for each spot
as well, and a sequence logo was prepared using WebLogo (weblogo.
berkeley.edu/).
Data Availability. The atomic coordinates and structure factors of GID4-
IGLWKS and GID4-VGLWKS complexes have been deposited in the Protein
Data Bank (https://www.rcsb.org/) under the accession codes 6WZX and
6WZZ, respectively. All other relevant data in the paper are entirely avail-
able through both text and figures in the main text and SI Appendix
(122, 123).
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